Chapter 13: Peripheral T-Cell and NK-Cell Neoplasms Flashcards

1
Q

These categories include a heterogeneous group of neoplasms having phenotypes resembling
mature T cells or NK cells.

Peripheral T-cell tumors make up about 5% to 10% of NHLs in the United States and Europe, but are more common in Asia.

NK-cell tumors are rare in the West,
but also more common in the Far East.

Only the most common diagnoses and those of
particular pathogenetic interest will be discussed.

A
  • Peripheral T-Cell Lymphoma, Unspecified
  • Anaplastic Large-Cell Lymphoma (ALK Positive)
  • Adult T-Cell Leukemia/Lymphoma
  • Mycosis Fungoides/Sézary Syndrome
  • Large Granular Lymphocytic Leukemia
  • Extranodal NK/T-Cell Lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Peripheral T-Cell Lymphoma, Unspecified?

A

Although the WHO classification includes a number of distinct peripheral T-cell neoplasms,
many of these lymphomas are not easily categorized and are lumped into a “wastebasket”
diagnosis,
peripheral T-cell lymphoma, unspecified .

  • As might be expected, no morphologic
  • feature is pathognomonic, but certain findings are characteristic.
  • These tumors efface lymphnodes diffusely and are typically composed of a pleomorphic mixture of variably sized malignant T cells ( Fig. 13-22 ).
  • There is often a prominent infiltrate of reactive cells, such as eosinophils and macrophages, probably attracted by tumor-derived cytokines.
  • Brisk neoangiogenesis mayalso be seen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A

FIGURE 13-22 Peripheral T-cell lymphoma, unspecified (lymph node). A spectrum of small,
intermediate, and large lymphoid cells, many with irregular nuclear contours, is visible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is required in the diagnosis of Peripheral T-Cell Lymphoma, Unspecified?

A

The diagnosis requires immunophenotyping.

By definition, all peripheral T-cell lymphomas have
a mature T-cell phenotype.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the immunophenotype of Peripheral T cell Lymphoma, unspecified?

A

They usually express CD2, CD3, CD5, and either αβ or γδ T-cell receptors.

Some also express CD4 or CD8; such tumors are t aken to be of helper or cytotoxic
T-cell origin, respectively.

However, many tumors have phenotypes that do not resemble any known normal T cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In difficult cases where the differential diagnosis lies between lymphoma and a florid reactive process, what analysis can be used to confirm the presence of clona T-cell receptor rearrangements?

A

DNA analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical features of Peripheral T-Cell Lymphoma, Unspecified?

A

Most patients present with generalized lymphadenopathy, sometimes accompanied by
eosinophilia, pruritus, fever, and weight loss
.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the prognosis of Peripheral T-cell Lymphoma, unspecified?

A

Although cures of peripheral T-cell lymphoma have
been reported,
these tumorshave a significantly worse prognosisthan comparably aggressive
mature B-cell neoplasms
(e.g., diffuse large B-cell lymphoma).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Anaplastic Large-Cell Lymphoma (ALK Positive)?

A

This uncommon entity is defined by the presence of rearrangements in the ALK gene on
chromosome 2p23.

These rearrangements break the ALK locus and lead to the formation of chimeric genes encoding ALK fusion proteins, constitutively active tyrosine kinases that trigger a number of signaling pathways, including the JAK/STAT pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the composition of Anaplastic Large-Cell Lymphoma (ALK Positive)?

A

As the name implies, this tumor is typically composed of large anaplastic cells, some containing horseshoe-shaped nuclei and voluminous cytoplasm (so-called hallmark cells) ( Fig. 13-23A ).
The tumor cells often cluster about venules and infiltrate lymphoid sinuses, mimicking the
appearance of metastatic carcinoma.

ALK is not expressed in normal lymphocytes or other
lymphomas;
thus, thedetection of ALK protein in tumor cells ( Fig. 13-23B ) is a reliable
indicator of an ALK gene rearrangement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are hallmark cells?

A

As the name implies, this tumor is typically composed of large anaplastic cells, some containing horseshoe-shaped nuclei and voluminous cytoplasm (so-called hallmark cells) ( Fig. 13-23A ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does the ALK mimick the
appearance of metastatic carcinoma?

A

The tumor cells often cluster about venules and infiltrate lymphoid sinuses,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is detection of ALK protein in tumor cells ( Fig. 13-23B ) is a reliable
indicator of an ALK gene rearrangement.

A

ALK is not expressed in normal lymphocytes or other
lymphoma
s; thus, the detection of ALK protein in tumor cells ( Fig. 13-23B ) is a reliable
indicator of an ALK gene rearrangement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A

FIGURE 13-23 Anaplastic large-cell lymphoma.

  • A, Several “hallmark” cells with horseshoelike or “embryoid” nuclei and abundant cytoplasm lie near the center of the field.
  • B, Immunohistochemical stain demonstrating the presence of ALK fusion protein.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T-cell lymphomas with ALK rearrangements tend to occur in what age?

A

children or young adults,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does ALK carry a very good prognosis(unlike other aggressive peripheral T-cell neoplasms)?

A

frequently involve soft tissues,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the cure rate with chemotherapy in ALK?

A

75% to 80%.

Inhibitors of ALK
are under development and offer an excellent opportunity for the development of a selective,
targeted therapy

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Morphologically similar tumors lacking ALK rearrangements occur in what age group?

A

in older
adults and have a poor prognosis
, similar to that of peripheral T-cell lymphoma, unspecified

19
Q

What is Adult T-Cell Leukemia/Lymphoma?

A

This neoplasm of CD4+ T cells is only observed in adults infected by human T-cell leukemia
retrovirus type 1 (HTLV-1),
which was discussed in Chapter 7 .

It occurs mainly in regions where
HTLV-1 is endemic, namely southern Japan, West Africa, and the Caribbean basin.

20
Q

What are the common findings in Adult T-Cell Leukemia/Lymphoma?

A
  • skin lesions,
  • generalized lymphadenopathy,
  • hepatosplenomegaly,
  • peripheral blood lymphocytosis, and
  • hypercalcemia.
21
Q

What are the appearance of the tumor cells Adult T-Cell Leukemia/Lymphoma?

A

varies, but cells with multilobated nuclei (“cloverleaf” or “flower” cells) are frequently observed.

22
Q

What is the pathogenesis of Adult T-Cell Leukemia/Lymphoma?

A

The tumor cells
contain clonal HTLV-1 provirus, which is believed to play a critical pathogenic role.

Notably,

  • *HTLV-1 encodes a protein called Tax** that is a potent activator of NF-κB, [49] which (as we have
    discussed) enhances lymphocyte growth and survival.
23
Q

What is the course of Adult T-Cell Leukemia/Lymphoma?

A
  • Most patients present with rapidly progressive disease that is fatal within months to 1 year despite aggressive chemotherapy.
  • Less commonly, the tumor involves only the skin and follows a much more indolent course, like that of mycosis fungoides (described below).
24
Q

Adult T-Cell Leukemia/Lymphoma , HTLV-1 infection sometimes gives rise to what?

A

to a progressive demyelinating disease of the central nervous system and spinal cord (see

Chapter 28 ).

25
Q

What is Mycosis Fungoides/Sézary Syndrome?

A

Mycosis fungoides and Sézary syndrome are different manifestations of a tumor of CD4 +
helper T cells that home to the skin.

26
Q

What is the clinical course of Mycosis Fungoides/Sézary Syndrome?

A

Clinically, the cutaneous lesions of mycosis fungoides
typically progress through three somewhat distinct stages:

  • an inflammatory premycotic phase,
  • a plaque phase, and
  • a tumor phase (all discussed in more detail in Chapter 25 ).
27
Q

What is the histolgical appearance of Mycosis Fungoides?

A
  • epidermis and upper dermis are infiltrated by neoplastic T cells, which often have a cerebriform appearance due to marked infolding of the nuclear membrane.
  • Late disease progression is characterized by extracutaneous spread, most commonly to lymph nodes and bone marrow.
28
Q

What is Sézary syndrome?

A

is a variant in which skin involvement is manifested as a generalized
exfoliative erythroderma.

29
Q

What is the distinction of Sézary syndrome from mycosis fungoides?

A
  • the skin lesions rarely proceed to tumefaction ( action or process of swelling or becoming tumorous), and
  • there is an associated leukemia of “Sézary” cells with characteristic cerebriform nuclei
30
Q

What is the immunophenotype of Mycosis Fungoides/Sézary Syndrome?

A

The tumor cells characteristically express the adhesion molecule CLA and the chemokine
receptors CCR4 and CCR10
, all of whichcontribute to the homing of normal CD4+ T cells to
the skin.

31
Q

What dominates in the clinical picture of Mycosis Fungoides/Sézary Syndrome?

.

A

Although cutaneous disease dominates the clinical picture, s_ensitive molecular
analyses have shown that the tumor cells circulate through the blood, marrow, and lymph nodes
even early in the course. Nevertheless, these are indolent tumors,
_

32
Q

What is the median survival of Mycosis Fungoides/Sézary Syndrome?

A

with a median survival of 8 to
9 years.

Transformation to aggressive T-cell lymphoma occurs occasionally as a terminal event.

33
Q

What are the variants ofLarge Granular Lymphocytic s Le ukemia?

A
  • T-cell and
  • NK-cell variants
34
Q

What is fLarge Granular Lymphocytic s Le ukemia?

A
  • rare neoplasm
  • both variants of which occur mainly in
  • adults.
  • Individuals with T-cell disease usually present with mild to moderate lymphocytosis and splenomegaly. Lymphadenopathy and hepatomegaly are usually absent.
  • NK-cell disease often presents in an even more subtle fashion, with little or no lymphocytosis or splenomegaly
35
Q

What is the appearance of Large Granular Lymphocytic Leukemia tumor cells?

A

The tumor cells are large lymphocytes with abundant blue cytoplasm and a few coarse
azurophilic granules, best seen in peripheral blood smears.

The marrow usually contains
sparse interstitial lymphocytic infiltrates, which can be difficult to appreciate without immunohistochemical stains.

Infiltrates are also usually present in the spleen and liver.

As might be expected, T-cell variants are CD3+, whereas NK-cell large granular lymphocytic leukemias
are CD3-, CD56+.

36
Q

What dominate the clinical
picture ofLarge Granular Lymphocytic Leukemia

A

neutropenia and anemia

Despite the relative paucity of marrow infiltration,.

  • Neutropenia is often accompanied by a striking decrease in late myeloid forms in the marrow.
  • Rarely, pure red cell aplasia is seen.
  • There is also an increased incidence of rheumatologic disorders.
  • Some patients with Felty syndrome, a triad of rheumatoid arthritis, splenomegaly, and neutropenia, have this disorder as an underlying cause.
  • The basis for these varied clinical abnormalities is unknown, but autoimmunity, provoked in some way by the tumor, seems likely.
37
Q

What is Felty syndrome?

A

, a triad of :

  • rheumatoid arthritis,
  • splenomegaly,
  • and neutropenia
38
Q

What is the course of Large Granular Lymphocytic Leukemia?

A

The course is variable, being largely dependent on the severity of the cytopenias and their
responsiveness to low-dose chemotherapy or steroids.

In general, tumors of T-cell origin
pursue an indolent course, whereas NK-cell tumors behave more aggressively.

39
Q

In genera, which of Large Granular Lymphocytic Leukemia variant has an aggresive course?

A
  • Tumors of T-cell origin: indolent course
  • NK-cell tumors :behave more aggressively.
40
Q

What is the epidemiology of Extranodal NK/T-Cell Lymphoma?

A

This neoplasm is rare in the United States and Europe, but constitutes as many as 3% of NHLs
in Asia.

41
Q

What is Extranodal NK/T-Cell Lymphoma?

A

presents most commonly as a destructive nasopharygeal mass; less common sites of
presentation include the testis and the skin.

The tumor cell infiltrate typically surrounds and
invades small vessels, leading to extensive ischemic necrosis.

The tumor cell size is variable but
usually includes a large-cell component.

In touch preparations, large azurophilic granules are
seen in the cytoplasm of the tumor cells that resemble those found in normal NK cells.

42
Q

Extranodal NK/T-Cell Lymphoma, This form of lymphoma is highly associated with what?

A

EBV

Within individual patients, all of the tumor
cells contain identical EBV episomes, indicating that the tumor originates from a single EBVinfected
cell.

How EBV gains entry is uncertain, since the tumor cells fail to express CD21, a surface protein that serves as the B-cell EBV receptor. Most tumors are CD3- and lack T-cell
receptor rearrangements and express NK-cell markers, including a restricted set of killer-cell Iglike
receptors, supporting an NK-cell origin. No consistent chromosome aberration has been
described, and relatively little is known about the molecular pathogenesis beyond the
involvement of EBV.

43
Q

What is the prognosis of Extranodal NK/T-Cell Lymphoma?

A

Most extranodal NK/T-cell lymphomas are highly aggressive neoplasms that respond well to
radiation therapy
but areresistant to chemotherapy.Thus, theprognosis is poorin patientswith
advanced disease

44
Q
A